Blue Trust Inc. Has $12.05 Million Stock Position in Procter & Gamble Company (The) $PG

Blue Trust Inc. reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 0.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 75,626 shares of the company’s stock after selling 282 shares during the quarter. Blue Trust Inc.’s holdings in Procter & Gamble were worth $12,049,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Benjamin Edwards Inc. grew its position in shares of Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock worth $62,098,000 after buying an additional 199,258 shares during the period. Capital Investment Advisory Services LLC grew its position in shares of Procter & Gamble by 13.8% in the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock valued at $6,426,000 after purchasing an additional 4,562 shares during the period. World Investment Advisors grew its position in shares of Procter & Gamble by 6.0% in the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock valued at $8,677,000 after purchasing an additional 2,886 shares during the period. Concurrent Investment Advisors LLC grew its position in shares of Procter & Gamble by 26.4% in the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock valued at $20,451,000 after purchasing an additional 25,059 shares during the period. Finally, Diversify Wealth Management LLC grew its position in shares of Procter & Gamble by 10.3% in the 1st quarter. Diversify Wealth Management LLC now owns 23,719 shares of the company’s stock valued at $3,849,000 after purchasing an additional 2,210 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 3,986 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the sale, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. This represents a 7.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Jennifer L. Davis sold 3,227 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer owned 61,764 shares in the company, valued at approximately $9,402,333.72. This represents a 4.97% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 149,763 shares of company stock worth $23,421,279. Insiders own 0.20% of the company’s stock.

Procter & Gamble Trading Down 0.6%

NYSE PG opened at $149.69 on Friday. Procter & Gamble Company has a 52 week low of $149.45 and a 52 week high of $180.43. The stock has a market capitalization of $350.34 billion, a price-to-earnings ratio of 22.99, a PEG ratio of 3.99 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock’s 50 day moving average price is $155.24 and its two-hundred day moving average price is $159.53.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the prior year, the business posted $1.40 EPS. The business’s revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Analysts Set New Price Targets

PG has been the subject of several research analyst reports. Evercore ISI reiterated an “in-line” rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Berenberg Bank boosted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research report on Wednesday, September 17th. Wells Fargo & Company cut their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. JPMorgan Chase & Co. cut their target price on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research note on Friday. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $172.21.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.